Trial NCT02395692

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2015-00356
Secondary IDs: 1402 ABTC 1402 ABTC-1402 NCI-2015-00356 UM1CA137443

Last trial update was posted on 2019-04-04

MeSH Interventions

Temozolomide

MeSH Conditions

Glioblastoma

Other Conditions

Adult Brain Glioblastoma

Stopping Reasons

Pre-specified response criteria not met to proceed to next stage of study.

Limitations And Caveats

n for this study 31 subjects w/ a 2 stage design. 19 subjects were treated in stage one with TRC102 and TMZ in recurrent GBM. If no more than 2 responses were observed among the initial 19 patients the study would be terminated and declared negative

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID